19 November 2017
News and Views
Links and Services
November's issue of Inflammatory Bowel Diseases reviews the performance of interferon-gamma release assays in patients with inflammatory bowel disease.
Guidelines mandate screening for latent tuberculosis infection prior to anti-tumor necrosis facto
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors